M-CSF neutralization and egr-1 deficiency prevent ovariectomy-induced bone loss.
about
RUNX3, EGR1 and SOX9B form a regulatory cascade required to modulate BMP-signaling during cranial cartilage development in zebrafishMechanism of stimulation of osteoclastic bone resorption through Gas6/Tyro 3, a receptor tyrosine kinase signaling, in mouse osteoclasts.Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation.Estrogen action on bone marrow osteoclast lineage cells of postmenopausal women in vivo.Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo.Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580.An IL-7-dependent rebound in thymic T cell output contributes to the bone loss induced by estrogen deficiency.Krox20/EGR2 deficiency accelerates cell growth and differentiation in the monocytic lineage and decreases bone massOvariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand.Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiencyOsteoclasts lacking Rac2 have defective chemotaxis and resorptive activity.Loss of transcription factor early growth response gene 1 results in impaired endochondral bone repair.IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation.Selective deletion of the membrane-bound colony stimulating factor 1 isoform leads to high bone mass but does not protect against estrogen-deficiency bone loss.Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator.Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activationBone remodeling in post-menopausal osteoporosis.The p85alpha subunit of class IA phosphatidylinositol 3-kinase regulates the expression of multiple genes involved in osteoclast maturation and migration.Targeted overexpression of the two colony-stimulating factor-1 isoforms in osteoblasts differentially affects bone loss in ovariectomized miceFunctional characterization of genetic variation in the Frizzled 1 (FZD1) promoter and association with bone phenotypes: more to the LRP5 story?Ovariectomy expands murine short-term hemopoietic stem cell function through T cell expressed CD40L and Wnt10B.Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha.Macrophage colony-stimulating factor (CSF1) controls monocyte production and maturation and the steady-state size of the liver in pigs.Estrogen prevents bone loss through transforming growth factor beta signaling in T cells.FMS Kinase Inhibitors: Current Status and Future Prospects.IL-34 and CSF-1: similarities and differences.12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.Macrophages and skeletal health.Osteomacs and Bone Regeneration.Dysregulation of CXCL9 and reduced tumor growth in Egr-1 deficient miceImmune system-related differentially expressed genes, transcription factors and microRNAs in post-menopausal females with osteopenia.Epidermal α6β4 integrin stimulates the influx of immunosuppressive cells during skin tumor promotionSelective deletion of the soluble Colony-Stimulating Factor 1 isoform in vivo prevents estrogen-deficiency bone loss in mice.Key Triggers of Osteoclast-Related Diseases and Available Strategies for Targeted Therapies: A Review.EGR1 supports the osteogenic differentiation of dental stem cells.Effect of cigarette smoke inhalation and estrogen deficiency on bone healing around titanium implants: a histometric study in rats.Early growth response gene 1 regulates bone properties in mice.Biglycan deficiency interferes with ovariectomy-induced bone loss.Bone- and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis.
P2860
Q27334714-6E93BB4F-6775-4A0F-97B0-2478294C82CAQ31577127-D6D840F1-36A3-4A55-BAE3-00CAA8E6EA88Q31717820-ECCF9D38-9BAD-49B3-BFE1-02FFD2351930Q33742652-5AFD9025-FB33-47F2-A55F-657C1C999652Q33950241-B14B8AB4-13D9-42C7-98F6-20B15A4C3F2DQ34115782-2347A9EC-5913-42BC-A199-F92CFBD39225Q34133202-D6E4A861-294C-473E-8B8D-A3D3BC4CCE2AQ34310928-B8BA7970-269E-4584-B47F-E1E14B390426Q34490668-F52A339A-2D13-4C2F-9F29-3B63179A13C9Q34816640-B24B603C-7D0E-43A5-B409-17464617010FQ35163388-BAA6DD81-87F8-4D53-8BAE-666D42DEE4B6Q35202895-B0545909-C99B-4E81-92B4-AE5F3A6A5D21Q35219971-78077C64-5C26-4E3E-AF99-048777B715B4Q35230310-2C2D914D-79E0-46D7-95E5-375879289D7DQ35918333-C3B79F36-3694-44EB-BCFA-816307908312Q36002625-B79A54CE-F9FC-4E68-AD6C-90FE6159210AQ36518536-6EB397A3-7305-4DA2-B2A3-B5288A3D70D3Q36994766-56BA7D23-D1C0-4623-BF36-D6BACB26FE5CQ37162248-1A818D2F-906E-4A5B-99AE-E5A45770034DQ37209139-BFA86D53-1E93-4632-AEB4-993BA54E2C99Q37215124-0D60F313-74E2-47E4-B3D1-B5B934890B22Q37271202-E281BE03-DD86-4287-9E8D-C9CF2AC078BFQ37360584-D368CB45-D332-4A49-AA14-DB2573E365E4Q37692440-1803D51A-9C7B-4AAD-AFEE-018C5D35D5C2Q37995562-EAEA832F-AE82-4FE8-830B-270B10C76797Q38112353-7FE2CE10-18BA-4FC8-942E-E3FA19D32A5BQ38346899-300B0699-47F0-428D-AE4A-2F31CFA66B23Q39129914-34DCBD3B-BECE-4FB9-82C5-5BE9AA6FF8AEQ39396797-E9015729-D631-409E-B267-9D0A6F7FDD4FQ39886429-E05C6D06-E7D6-47BA-9F76-362117F6CC6DQ41614826-59B02830-16CA-4B23-A734-964CD5BF95E6Q42541724-01E608AC-4DEA-4326-97E0-343A644D30D7Q44510030-F6A6B8AA-5FA5-474C-B17C-A9EB8A6F17F1Q47400369-9EBD4AC6-5EC6-46F7-81EA-FAF69BA59687Q50473398-F2D795F3-3700-487C-979F-EABEE3665131Q51235086-B489E73E-729E-47AA-9A1A-B42E723B7760Q51469341-5D676E4C-5D51-4C05-A644-DDFF13EC6346Q53908803-9151E47D-A291-4F9A-842B-4F6B601E97F3Q54369171-26E6E6EE-4B2D-475F-A8FB-5CB205DED580
P2860
M-CSF neutralization and egr-1 deficiency prevent ovariectomy-induced bone loss.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
M-CSF neutralization and egr-1 deficiency prevent ovariectomy-induced bone loss.
@ast
M-CSF neutralization and egr-1 deficiency prevent ovariectomy-induced bone loss.
@en
type
label
M-CSF neutralization and egr-1 deficiency prevent ovariectomy-induced bone loss.
@ast
M-CSF neutralization and egr-1 deficiency prevent ovariectomy-induced bone loss.
@en
prefLabel
M-CSF neutralization and egr-1 deficiency prevent ovariectomy-induced bone loss.
@ast
M-CSF neutralization and egr-1 deficiency prevent ovariectomy-induced bone loss.
@en
P2093
P2860
P356
P1476
M-CSF neutralization and egr-1 deficiency prevent ovariectomy-induced bone loss
@en
P2093
M A Gentile
M N Weitzmann
R Pacifici
P2860
P304
P356
10.1172/JCI8672
P407
P50
P577
2000-05-01T00:00:00Z